PD1 Proteins, Antibodies, Inhibitors, and Constructs
Recombinant human PD1 proteins, mouse PD1 proteins, and rat PD1 proteins; recombinant anti-human PD1 antibodies, human PD1 inhibitors, recombinant anti-mouse PD1 antibodies.
March 5, 2022
Durvalumab Biosimilar, Endotoxin 0.05 EU/mg | C025P.05
Durvalumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Durvalumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Atezolizumab Biosimilar, Human IgG4 S228P Mutant | C024P.4S
Atezolizumab Biosimilar, Human IgG4 S228P Mutant. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
Atezolizumab Biosimilar, Mouse IgG2a L234A L235A P329G (LALAPG) Fc Silent Mutant | C024P.m2aLA
Atezolizumab Biosimilar, Mouse IgG2a L234A L235A P329G (LALAPG) Fc Silent Mutant. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds...
Atezolizumab Biosimilar, Mouse IgG2a | C024P.m2a
Atezolizumab Biosimilar, Mouse IgG2a. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
Atezolizumab Biosimilar, Human IgG4 S228P Mutant, Endotoxin 0.05 EU/mg | C024P.4S.05
Atezolizumab Biosimilar, Human IgG4 S228P Mutant, Endotoxin 0.05 EU/mg. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks...
Atezolizumab Biosimilar, Endotoxin 0.05 EU/mg | C024P.05
Atezolizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.